Anne M. Phillips
Director · Barinthus Biotherapeutics plc.
- 2026
- Sep 9, 2026
- 3
Summary
Latest filing:
Anne M. Phillips is Director of Barinthus Biotherapeutics plc. (BRNS). 3 SEC Form 4 filings on record, most recently on 9 September 2026.
Recent transactions
1The latest SEC Form 4 transaction reported by Anne M. Phillips.
Trading pattern
InsiderAlpha's records for Anne M. Phillips go back to 2026: 3 primary Form 4 filings, an average of 3.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same sector
No other insider has filed at Anne M. Phillips's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- WARBURG PINCUS CO. - $1.12B in SHC purchases and sales in the last 12 months
- CP Circle ML Holdco GP, LLC - $1.07B in MDLN purchases and sales in the last 12 months
- TC Group Cayman Investment Holdings, L.P. - $1.07B in MDLN purchases and sales in the last 12 months
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Anne M. Phillips?
Anne M. Phillips is a corporate insider, tracked as Director of Barinthus Biotherapeutics plc. (BRNS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Anne M. Phillips submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.